Literature DB >> 34604408

Evaluation of Oxidative Stress, Apoptosis, and Expression of MicroRNA-208a and MicroRNA-1 in Cardiovascular Patients.

Asma Mohammadi1, Ali Reza Balizadeh Karami2, Vahid Dehghan Mashtani2, Tooba Sahraei1, Zeinab Bandani Tarashoki2, Ehsan Khattavian2, Sara Mobarak1, Hossein Moradi Kazerouni2, Esmat Radmanesh1,2.   

Abstract

BACKGROUND: MicroRNA expression signature and reactive oxygen species (ROS) production have been associated with the development of cardiovascular diseases (CVDs). This study aimed to evaluate oxidative stress, inflammation, apoptosis, and the expression of miRNA-208a and miRNA-1 in cardiovascular patients.
METHODS: The study population included four types of patients (acute coronary syndromes (ACS), myocardial infarction (MI), arrhythmia, and heart failure (HF)), with 10 people in each group, as well as a control group. Quantitative real-time PCR was performed to measure mir-208 and miR-1 expression, the mRNAs of inflammatory mediators (TNFα, iNOS/eNOS), and apoptotic factors (Bax and Bcl2). XOX, MDA, and antioxidant enzymes (CAT, SOD, and GPx) were measured by ZellBio GmbH kits by an ELISA Reader.
RESULTS: The results showed significant decreases in the activity of antioxidant enzymes (CAT, SOD, and Gpx) and a significant increase in the activity of the MDA and XOX in cardiovascular patients. Significant increases in IL-10, iNos, iNOS / eNOS, and TNF-α in cardiovascular patients were also observed. Also, a significant increase in the expression of miR-208 (HF> arrhythmia> ACS> MI) and a significant decrease in the expression of miR-1 (ACS> arrhythmia> HF> MI) were found in all four groups in cardiovascular patients.
CONCLUSION: The results showed increases in oxidative stress, inflammation, apoptotic factors, and in the expression of miR-208a in a variety of cardiovascular patients (ACS, MI, arrhythmia, and HF). It is suggested that future studies determine the relationships that miR-1, miR-208, and oxidative stress indices have with inflammation and apoptosis.

Entities:  

Keywords:  Apoptosis; Cardiovascular diseases; Inflammation; Oxidative stress; microRNA-1; microRNA-208a

Year:  2021        PMID: 34604408      PMCID: PMC8480300          DOI: 10.52547/rbmb.10.2.183

Source DB:  PubMed          Journal:  Rep Biochem Mol Biol        ISSN: 2322-3480


  44 in total

Review 1.  Acute coronary syndrome in the Asia-Pacific region.

Authors:  Mark Y Chan; Xin Du; David Eccleston; Changsheng Ma; Padinhare P Mohanan; Manabu Ogita; Kou-Gi Shyu; Bryan P Yan; Young-Hoon Jeong
Journal:  Int J Cardiol       Date:  2015-04-11       Impact factor: 4.164

2.  Circulating microribonucleic acids miR-1, miR-21 and miR-208a in patients with symptomatic heart failure: Preliminary results.

Authors:  Grażyna Sygitowicz; Mariusz Tomaniak; Olga Błaszczyk; Łukasz Kołtowski; Krzysztof J Filipiak; Dariusz Sitkiewicz
Journal:  Arch Cardiovasc Dis       Date:  2015-10-21       Impact factor: 2.340

3.  Gene expression of antioxidative enzymes in the human heart: increased expression of catalase in the end-stage failing heart.

Authors:  S Dieterich; U Bieligk; K Beulich; G Hasenfuss; J Prestle
Journal:  Circulation       Date:  2000 Jan 4-11       Impact factor: 29.690

4.  Role of nitric oxide and oxidative stress in a sheep model of persistent atrial fibrillation.

Authors:  Ilse Lenaerts; Ronald B Driesen; Nerea Hermida; Nerea Hermida Blanco; Patricia Holemans; Hein Heidbüchel; Stefan Janssens; Jean-Luc Balligand; Karin R Sipido; Rik Willems
Journal:  Europace       Date:  2013-02-17       Impact factor: 5.214

5.  Association between activities of SOD, MDA and Na+-K+-ATPase in peripheral blood of patients with acute myocardial infarction and the complication of varying degrees of arrhythmia.

Authors:  Yu Yin; Wei Han; Ying Cao
Journal:  Hellenic J Cardiol       Date:  2018-04-24

6.  Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure.

Authors:  P Ferdinandy; H Danial; I Ambrus; R A Rothery; R Schulz
Journal:  Circ Res       Date:  2000-08-04       Impact factor: 17.367

7.  No increase of plasma malondialdehyde after primary coronary angioplasty for acute myocardial infarction.

Authors:  Karin Aström Olsson; Jan Harnek; Ann-Kristin Ohlin; Natascia Pavlidis; Björn Thorvinger; Hans Ohlin
Journal:  Scand Cardiovasc J       Date:  2002-08       Impact factor: 1.589

8.  Altered expression of hyperpolarization-activated cyclic nucleotide-gated channels and microRNA-1 and -133 in patients with age-associated atrial fibrillation.

Authors:  Yao-Dong Li; Yi-Fan Hong; Yueerguli Yusufuaji; Bao-Peng Tang; Xian-Hui Zhou; Guo-Jun Xu; Jin-Xin Li; Lin Sun; Jiang-Hua Zhang; Qiang Xin; Jian Xiong; Yu-Tong Ji; Yu Zhang
Journal:  Mol Med Rep       Date:  2015-05-25       Impact factor: 2.952

Review 9.  Vascular Inflammation and Oxidative Stress: Major Triggers for Cardiovascular Disease.

Authors:  Sebastian Steven; Katie Frenis; Matthias Oelze; Sanela Kalinovic; Marin Kuntic; Maria Teresa Bayo Jimenez; Ksenija Vujacic-Mirski; Johanna Helmstädter; Swenja Kröller-Schön; Thomas Münzel; Andreas Daiber
Journal:  Oxid Med Cell Longev       Date:  2019-06-23       Impact factor: 6.543

10.  Circulating cardio-enriched microRNAs are associated with long-term prognosis following myocardial infarction.

Authors:  Olof Gidlöf; J Gustav Smith; Kazuma Miyazu; Patrik Gilje; Anna Spencer; Sten Blomquist; David Erlinge
Journal:  BMC Cardiovasc Disord       Date:  2013-02-28       Impact factor: 2.298

View more
  2 in total

1.  Lectin-Like OLR1 3'UTR Rs1050286 Gene Polymorphism and Plasma Oxidized-LDL in Coronary Artery Disease and Their Relation to Cardiovascular Risk and Outcomes.

Authors:  Hanan Sharaf El-Deen Mohammed; Manal Mohamed Kamal; Hala Mostafa ElBadre; Amal Hosni; Azza Abo Elfadl; Mohamed Ahmed Mostafa; Reham Ibrahim El-Mahdy
Journal:  Rep Biochem Mol Biol       Date:  2022-01

Review 2.  Hepatocellular Carcinoma and Obesity, Type 2 Diabetes Mellitus, Cardiovascular Disease: Causing Factors, Molecular Links, and Treatment Options.

Authors:  Chunye Zhang; Shuai Liu; Ming Yang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-23       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.